Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.

There is no information available on the relation between response to chemotherapy and the high-risk phenotype assessed by uPA and/or PAI-1. The clinical situation of neoadjuvant chemotherapy provides a means of rapidly assessing the sensitivity of the primary tumour to cytotoxic drug regimens. The...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pierga, J. Y., Lainé-Bidron, C., Beuzeboc, P., De Crémoux, P., Pouillart, P., Magdelénat, H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 1997
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2227990/
https://ncbi.nlm.nih.gov/pubmed/9275033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi